News | January 27, 2022
Covaxin and Covishield granted conditional market approval
The vaccines are currently only authorised for emergency use in the country
The vaccines are currently only authorised for emergency use in the country
This will evaluate the immunogenicity, safety, and reactogenicity of a single booster dose in adults aged 18 years and older
It meets stringent requirements for ensuring the safe storage and efficacy of temperature-sensitive vaccines, including those for Covid-19
CEQUA’s nanomicellar (NCELL) technology improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration
According to IQVIA sales data for the 12-month period ending November 2021, the Ziac tablets, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg market achieved annual sales of approximately US $ 30.3 million
Antibiotics mixed in wastewater often get disposed of into the water bodies resulting in wider antimicrobial resistance cases
Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
Urges them to focus on tele-consultation like eSanjeevani and efficient monitoring of those in home isolation
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
